Digital smoking cessation company 2Morrow has partnered with GlaxoSmithKline, makers of Nicoderm patches, to offer the company’s Nicoderm CQ Patch to smokers who complete 2morrow’s cessation program.
Smoking Cessation App-Maker Partners with GSK to Offer Nicotine Patches.
Previous
Previous
Digital Medicine's March on Chronic Disease
Next
Next